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proportional to the number of small, 
dynamic adhesions within the cell. 
The data from Gupton and Water-
man-Storer (2006) suggest that low 
fibronectin is suboptimal for migra-
tion because there are too few adhe-
sions even though the adhesions are 
dynamic. High fibronectin is subop-
timal because the adhesions are too 
stable and do not signal. Cells on 
intermediate fibronectin have a high 
number of small, dynamic adhesions 
of the kind that are known to signal 
to Rac and Cdc42. Thus, the over-
all rates of both integrin ligation and 
adhesion assembly should be maxi-
mal, leading to high Rac and Cdc42 
activity. These simple dynamics may 
be the key factor driving lamellipodial 
actin polymerization and flow.
The differential effects on Rho 
activity can also be understood if 
we consider integrin activation of 
Rho, which is temporally biphasic 
(Ren et al., 1999). Following new 
integrin ligation, Rho activity first 
decreases, followed by an increase 
at later times. Thus, young adhe-
sions appear to inhibit Rho, whereas 
more mature adhesions activate it. 
As adhesion lifetimes increase in 
direct proportion to the concentra-
tion of fibronectin, these results may 
explain why Rho activity correlates 
with fibronectin.
This study has revealed some 
major insights and represents a large 
step in our understanding of cell 
migration. However, there are more 
chapters to be written. The actin-
integrin linkage is a critical site that 
integrates adhesion, signaling, and 
protrusion; its regulation remains to 
be parsed. The “clutch” mechanisms 
by which myosin II-mediated tension 
regulates both adhesion assembly 
and disassembly may depend on the 
state of the adhesion, which remains 
to be defined. Finally, some highly 
motile cells do not show the highly 
organized adhesions and actin fila-
ments seen in fibroblasts or epithelial 
cells migrating on fibronectin yet can 
show optima in migration speed that 
are dependent on substrate concen-
tration. The factors that produce this 
relationship in these cells remain to 
be established.
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Hormones trigger dramatic changes in the structure and transcriptional activity of specific 
promoters that lead to exchange of repression complexes for activation complexes. Ju et 
al. (2006) now show that estrogen-dependent restructuring and transcription of the pS2 
promoter require the generation of a DNA double-strand break by a novel protein complex 
containing two enzymes, topoisomerase IIβ and poly(ADP-ribose) polymerase.Higher eukaryotes invest consider-
able capital in carefully regulating 
thousands of genes. These genes 
are not only expressed at the cor-
rect time, place, and level, but many of these genes must respond rapidly 
and specifically to multiple develop-
mental, nutritional, and environmen-
tal signals. To this end, sophisticated 
mechanisms of transcriptional regu-Cell 125,lation have evolved. One major class 
of factors that provides the selectiv-
ity of a gene’s transcriptional regula-
tion is sequence-specific DNA bind-
ing transcription factors. These in  June 30, 2006 ©2006 Elsevier Inc. 1225
figure 1. effects of TopoIIβ and PARP-1 on the pS2 Promoter
Shown is a timecourse depicting changes—DNA cleavage and the exchange of factors—at the 
pS2 promoter centered on the estrogen response element (ERE) following estradiol treatment, 
which causes transcription activation. This figure is based on data and a model presented in Ju 
et al. (2006). In most cases, binding of factors to the individual nucleosomes (NucU, NucE, and 
NucT) was assayed, whereas in some cases, the entire region encompassing all three nucleo-
somes was assayed (indicated by brackets). For PARP-1 and H1, weaker association is indicated 
by a dotted outline of these factors. The TopoIIβ complex shown at the 10 min and 30 min time 
points also contains DNAPK, Ku86, and Ku70. The ERα shown represents a homodimer.turn bind to a diverse set of coregu-
lators that can recruit RNA polymer-
ase II (Pol II) or modify chromatin 
to promote or inhibit transcription. 
In a recent paper in Science, Ju et 
al. (2006) add a new and interest-
ing dimension to signal-regulated 
gene activation in their studies of the 
estrogen-responsive pS2 gene. They 
show that estrogen-dependent tran-
scription of pS2 requires a promoter 
intermediate containing a double-
strand break (DSB). In addition, they 
demonstrate that the DSB is gener-
ated by a protein complex contain-
ing two enzymes, topoisomerase 
II (TopoIIβ) and poly(ADP-ribose) 
polymerase (PARP-1), each of which 
is required for transcription activation 
and participates in a variety of other 
nuclear processes (Figure 1).
TopoII is an enzyme with dou-
ble-strand cleavage and ligation 
activities that catalyzes topological 
changes by allowing the passage 
of one DNA helix through another. 
TopoII is involved in several nuclear 
functions, including chromosome 
segregation, chromosome conden-
sation, DNA replication, genome 
stability, and chromosome organi-
zation (Austin and Marsh, 1998). 
The TopoII activity in vertebrates 
is encoded by two distinct genes, 
α and β. TopoIIα appears to be 1226 Cell 125, June 30, 2006 ©2006 Elsrequired for chromosome conden-
sation and segregation, whereas 
the role of TopoIIβ is less well 
understood (Austin and Marsh, 
1998). TopoII’s function in tran-
scription and its regulation have 
been a subject of speculation and 
investigation for decades, in part 
because TopoII’s ability to create 
a DSB in DNA provides a means of 
resolving topological barriers, such 
as the supercoiling induced during 
transcription and other chromo-
somal processes. In this regard, 
previous studies have mapped 
TopoII cleavage sites to the 5′ ends 
of some genes and localized the 
distinct, but related, enzyme TopoI 
to actively transcribed regions 
(Kroeger and Rowe, 1992).
PARP-1, the most abundantly 
expressed member of a family of 
PARP proteins, catalyzes the polym-
erization of ADP-ribose units from 
donor NAD+ molecules on target 
proteins (Kim et al., 2005). PARP-
1 and the poly(ADP-ribosyl)ation 
of proteins are involved in DNA 
repair, cell death, mitotic appa-
ratus function, chromatin regula-
tion, and transcription regulation 
(Kim et al., 2005). In addition to 
its catalytic activity, PARP-1 also 
binds to DNA through its double 
zinc finger DNA binding domain. evier Inc.PARP-1 has low basal enzymatic 
activity that is allosterically stimu-
lated by single- and double-strand 
DNA breaks, protein binding part-
ners, and nucleosomes, providing 
a mechanism for the regulation of 
PARP-1-dependent functions. The 
targets of PARP-1 enzymatic activ-
ity include a variety of nuclear pro-
teins, including PARP-1 itself and 
histones, such as the linker histone 
H1. Recent studies have suggested 
a role for PARP-1 in the regulation 
of chromatin structure and tran-
scription (Ju et al., 2004; Kim et 
al., 2004; Pavri et al., 2005; Tulin 
and Spradling, 2003). For example, 
PARP-1 functions as a nucleosome 
binding factor that can regulate 
the extent of chromatin compac-
tion. In addition, PARP-1 acts as 
a promoter-specific exchange fac-
tor that promotes the binding and 
release of components of the tran-
scriptional machinery. PARP-1 has 
numerous other protein partners in 
the cell and functions in a variety 
of other cellular processes as well 
(Kim et al., 2005).
Ju et al. (2006) now show that 
TopoIIβ and PARP-1 collaborate 
in an interesting way that alters 
the molecular composition and 
structure of the pS2 promoter dur-
ing an estradiol (E2)-dependent 
transcriptional response. A previ-
ously identified PARP-1 corepres-
sor complex—containing nucleolin, 
nucleophosmin, and Hsp70 (Ju et 
al., 2004)—as well as the N-CoR 
and HDAC3 corepressors are asso-
ciated with the repressed promoter. 
E2 not only rapidly induces (within 
10 min) an increase in binding of 
estrogen receptor α (ERα) to the 
promoter but also causes a con-
comitant rapid exchange of the 
corepressors for what appears to 
be an activation complex containing 
PARP-1 and TopoIIβ. Interestingly, 
the activation complex also con-
tains Ku86/70 and DNA-PK, factors, 
which are normally associated with 
DNA damage and repair. At later 
times (30 min after treatment with 
E2), the acetyltransferase CBP and 
Pol II are recruited to the promoter 
to complete the activation process.
Interestingly, both PARP-1 and 
TopoIIβ enzymatic activities are 
critical for the activation of pS2 
transcription. Ju et al. (2006) show 
that chemical inhibitors of PARP-1, 
or microinjection of either PARP-1 
antibody or siRNA, inhibited ERα-
dependent gene activation. Resto-
ration of siRNA-mediated PARP-1 
knockdown required introduction 
of catalytically competent PARP-1. 
The definitive target of this PARP-
1 enzymatic activity has yet to be 
determined, although PARP-1 itself, 
H1, and TopoII can be poly(ADP-
ribosyl)ated and are thus candi-
dates (Darby et al., 1985; Kim et al., 
2004). In addition, Ju et al. (2006) 
used a specific TopoII inhibitor as 
well as transfection experiments 
with a TopoIIβ catalytic mutant to 
show that TopoII activity is required 
for the E2-dependent activation of 
pS2. What does the TopoIIβ enzy-
matic activity do? Ju et al. (2006) 
developed a sensitive method to 
demonstrate that a transient DSB 
occurs in promoter DNA adjacent 
to a nucleosome containing the 
DNA binding sequence for ERα 
(“NucE”). The formation of this 
DSB requires TopoIIβ enzymatic 
activity and participates in the sub-
sequent exchange of factors at the 
promoter. A possible role for the 
TopoIIβ-dependent DSB in stimu-
lating PARP-1 enzymatic activity 
has yet to be addressed.
In an elegant next step, Ju et al. 
(2006) examined the changes in 
factor occupancy at the pS2 pro-
moter by chromatin immunopre-
cipitation at the level of individual 
nucleosomes. They found that, 
prior to treatment with E2, PARP-1 
is associated with three adjacent 
nucleosomes in the promoter region 
(NucE and a nucleosome on each 
side, NucU and NucT), possibly 
acting as part of a repression com-
plex (Ju et al., 2004) or as a direct 
nucleosome binding factor (Kim et 
al., 2004) (Figure 1). Upon estro-
gen treatment, PARP-1 departs 
from NucU and NucT, perhaps as 
a consequence of auto poly(ADP-
ribosyl)ation, resulting in a loss of 
nucleosome binding activity (Kim et al., 2004). In addition, a PARP-
1/TopoIIβ activation complex con-
taining the nuclear receptor coacti-
vator ASC2 becomes concentrated 
on NucE. The factor dynamics on 
the three nucleosomes are accom-
panied by changes in chromatin 
structure. H1 is lost from NucE 
and is replaced with HMGB1/2, a 
nonhistone structural protein. The 
authors suggest that H1 could be 
a target for poly(ADP-ribosyl)ation 
by PARP-1, causing its release. 
Alternatively, PARP-1’s ability to 
compete with H1 for binding to 
nucleosomes could function in the 
dissociation of H1 from NucE (Kim 
et al., 2004).
The importance of the TopoIIβ-
dependent double-strand cleav-
age of the DNA upstream of NucE 
is most evident in the context of 
the exchange of factors at the pS2 
promoter. In this regard, Ju et al. 
(2006) showed that the changes 
in DNA and chromatin structure, 
as well as the subsequent recruit-
ment of the CBP coactivator and 
Pol II, are inhibited by merbarone, 
a TopoII inhibitor. What mechanistic 
role might the transient DSB at the 
promoter have? One could imagine 
that this cleavage resolves a topo-
logical barrier allowing a critical 
structural change in the promoter. 
The specific role of DSB and the 
details of the mechanistic inter-
play between TopoIIβ and PARP-
1 remain an important issue to 
resolve.
The generality of the observed 
pS2 promoter cleavage follow-
ing gene activation is an intriguing 
issue. Past studies have identified 
TopoII cleavage sites associated 
with hypersensitive sites in pro-
moter regions of uninduced Dro-
sophila hsp70 and constitutively 
active actin-5C genes (Kroeger and 
Rowe, 1992). In addition to pS2, Ju 
et al. (2006) observed recruitment 
of TopoIIβ and PARP-1 and other 
components of the complex to the 
PSA, RARβ, Dio1, and MMP12 pro-
moters upon gene activation, as 
well as promoter cleavage. The pro-
moter cleavage relative to the adja-
cent upstream and coding regions Cell 125, was not reported, but the enhanced 
cleavage of active compared to 
inactive promoters was clear. Future 
studies including genome-wide 
analyses would reveal if TopoIIβ 
promoter cleavage is broadly asso-
ciated with gene activation. Such 
broad mapping studies would 
need to be interpreted cautiously 
because nuclease hypersensitive 
regions associated with active or 
primed promoters could be for-
tuitous targets of TopoIIβ cleav-
age. To demonstrate that cleavage 
is a prerequisite of activation will 
require more thorough studies like 
those done by Ju et al. (2006) for 
the pS2 promoter. Additionally, one 
should keep in mind that promot-
ers come in many “flavors.” Many 
are primed for activation and have 
promoters occupied by basal tran-
scription factors and transcription-
ally paused Pol II (Lis, 1998). It will 
be of interest to see how many dis-
tinct classes of promoters require 
a specific DSB and at what stage 
cleavage plays a role in priming and 
activation.
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